글로벌 류마티스 관절염 치료 시장 - 2028년까지의 추세 및 예측

시장 분석 및 통찰력: 글로벌 류마티스 관절염 치료 시장

글로벌 류마티스 관절염 치료 시장은 2021년에서 2028년의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 상기 연구 예측 기간 동안 5.01%의 CAGR로 성장하고 있다고 분석합니다. 노령 인구 증가와 공공 및 정부 부문 모두의 연구 개발 투자가 이 시장 성장의 원인입니다.

다양한 라이프스타일 요인으로 인해 류마티스 관절염 발병률이 증가함에 따라 류마티스 관절염 치료 에 대한 더 좋고 영구적인 치료 옵션을 개발하기 위한 연구와 조사도 증가하여 재발률을 낮추고 시장 성장을 촉진합니다. 게다가 환자 수의 증가와 영구적인 결과를 가진 치료에 대한 수요 증가는 시장 성장의 기회로 작용합니다. 그러나 엄격한 규제 정책과 중증 환자의 경우 수술 비용이 엄청나게 많이 들기 때문에 류마티스 관절염 치료 시장이 방해를 받을 수 있습니다.

류마티스 관절염은 활막(관절을 덮고 있는 얇은 조직층)이 면역 체계의 표적이 되어 발생합니다. 류마티스 관절염은 영구적인 치료법이 없지만, 이 질환을 관리하는 데 도움이 되는 여러 가지 치료 옵션이 있습니다. WHO에 따르면, 류마티스 관절염의 유병률은 0.3%에서 1% 사이이며, 주로 35세에서 50세 사이에 발생하지만, 다른 연령대도 영향을 받습니다. 따라서 류마티스 관절염 치료 시장은 이점이 있습니다. 게다가, 더 영구적인 솔루션이 있는 치료에 대한 필요성은 류마티스 관절염 치료 시장에 큰 기회로 작용합니다. 그러나 다양한 치료 옵션이 있더라도, 질병을 관리하기 위한 수많은 홈 케어 관행의 가용성은 시장에 제약으로 작용할 수 있습니다.

This rheumatoid arthritis treatment market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Rheumatoid Arthritis Treatment Market Scope and Market Size

The rheumatoid arthritis treatment market is segmented on the basis of disease type, age, treatment type and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of disease type, the rheumatoid arthritis treatment market can be segmented into seropositive RA, seronegative RA and juvenile idiopathic arthritis (JIA).
• On the basis of age, the rheumatoid arthritis treatment market can be segmented into children and adults.
• On the basis of treatment type, the rheumatoid arthritis treatment market can be segmented into nutrition, medication, procedures, therapy and self – care.
• On the basis of end user, the rheumatoid arthritis treatment market can be segmented into hospitals, homecare, specialty clinics and others.

Rheumatoid Arthritis Treatment Country Level Analysis

The rheumatoid arthritis treatment market is analyzed and market size information is provided by country, disease type, age, treatment type and end user as referenced above.

The countries covered in the rheumatoid arthritis treatment market report are U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa.

On geographical estimation, North America is expected to experience tremendous growth during the forecast period due to the increasing number of research and development activities, technological advancements, active support from government and private sectors leading to tremendous increase in healthcare expenditure and rapidly increasing awareness about rheumatoid arthritis. Moreover, improvement and increase in well- established healthcare infrastructure also plays a key role in increasing the market in the region. Europe is also expected to have a huge increase in rheumatoid arthritis treatment market because of rising market player initiatives and developmental activities for production of new drugs and treatment methods. Asia-Pacific is estimated as the fastest growing market during the forecast period due to increasing financial support both from government and private sectors. Moreover, developing technologies in healthcare and major biotechnological advancements in countries such as Japan, South Korea, China and others are a major source for new research and developments.

The country section of the rheumatoid arthritis treatment market report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Global rheumatoid arthritis treatment market also provides you with detailed market analysis for patients’ uses and side effects. Rates at which rheumatoid arthritis treatment effect various conditions and schedules are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Rheumatoid Arthritis Treatment Market Share Analysis

Rheumatoid arthritis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to rheumatoid arthritis treatment market.

류마티스 관절염 치료 시장에서 다루는 주요 기업으로는 Abbvie Inc., Johnson & Johnson Services, Inc., Amgen Inc., Pfizer Inc., Zydus Cadila, Novartis AG, AstraZeneca, F. Hoffman-La Roche Ltd, Bristol-Myers Squibb Company, GlaxoSmithKline plc., Abbott, Gilead Sciences, Inc., Eli Lilly and Company, UCB SA, Belgium, Aclaris Therapeutics, Inc., Celgene Corporation, CANFITE BioPharma Ltd, Vertex Pharmaceuticals Incorporated, Sanofi, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc. 등이 있으며, 국내 및 글로벌 기업도 있습니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁사에 대한 경쟁 분석을 별도로 제공합니다.    

SKU-60860